FDA Products Containing Cannabis or Cannabis-Derived Compounds Public Hearing . Friday, May 31st, 2019
Hoban Law Group is delighted to announce that Managing Attorney Garrett Graff was selected by the U.S. Food and Drug Administration (“FDA”) to testify in Washington D.C. at the Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds Public Hearing on Friday, May 31, 2019.
This monumental hearing is the first time the FDA has requested feedback from stakeholders and the cannabis industry regarding the safety, manufacturing and sale of products containing cannabis-derived compounds, including cannabidiol (“CBD”). The hearing will provide stakeholders an opportunity to advocate for sensible rules and prudent regulation of CBD and other products that contain cannabis.
The hearing is scheduled to begin on Friday, May 31st at 8:00 A.M. and concludes at 6:00 P.M. (EDT). The hearing will be broadcasted live via webcast. A full recording of the hearing will be uploaded following its conclusion. Click here to view the webcast on May 31st.
How To Get Involved
We encourage stakeholders to take additional steps and to submit a comment to the FDA’s public docket during the open period. If you are interested in submitting comments after the hearing, comments must be posted to the public docket before July 2, 2019. Contact us to see how we can help to ensure that your voice is heard.